Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
Byungho Lim(Drug Discovery Laboratory (Norway)), Mirang Kim(Itami City Hospital)
Cited by 23
Related Papers
Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer
|Carcinogenesis|2013|105
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor–resistant lung cancer therapy
|Experimental & Molecular Medicine|2022|17